EmersonCPerinMDPhD

Interventional Cardiology

Medical Director, Texas Heart Institute; Director, Interventional Cardiology, BSLMC Medical Director BSLMC Catheterization Laboratory

Join to view full profile

Dr. Perin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Perin's full profile

Already have an account?

Office
6624 Fannin St
Ste 2600
Houston, TX 77030
Phone+1 713-790-9401

Fax+1 713-790-0353

Summary

I am a board certified interventional cardiologist specialized in performing coronary and peripheral interventions. I have achieved a level of excellence in these procedures and serve as the Director of the cardiac catheterization laboratory at Baylor St. Lukes Medical Center.
I have had a long-term interest in research and after founding the Stem Cell Center at the Texas Heart Institute in 2000 have developed stem cell treatments for cardiovascular disease over the last 15 years. I am a worldwide leader in stem cell therapy for heart failure and widely published in the field.
My institutional leadership lead to my appointment as Medical Director of the Texas Heart Institute in 2018.

Education & Training

Instituto de Cardiologia Fundação Universitária de CardiologiaPhD, Cardiology, 1993 - 1995
Baylor College of Medicine/Texas Heart Institute/Baylor St Luke's Medical CenterFellowship, Cardiovascular Disease, 1988 - 1991
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1985 - 1988
Federal University of Rio Grande do Sul School of MedicineClass of 1983

Certifications & Licensure

TX State Medical License 1991 - 2026
FL State Medical License 1987 - 1998
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

McNair Scholar Texas Heart Institute
America's Top Doctors Castle Connolly, 2006-2014
Top Doctors:SE Texas Castle Connolly, 2013
Fellow (FACC) American College of Cardiology
Join now to see all

Clinical Trials

Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF) Start of enrollment: 2004 Apr 01
Completed
Phase 1
NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions Start of enrollment: 2004 Apr 01
Completed
Phase 3
CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS) Start of enrollment: 2003 Aug 01
Completed
Phase 4
Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br) Start of enrollment: 2006 Apr 01
Completed
Phase 1
ALD-301 for Critical Limb Ischemia, Randomized Trial Start of enrollment: 2006 Oct 01
Completed
Phase 1, Phase 2
A Randomized Clinical Trial of Adipose-derived Stem Cells in Treatment of Non Revascularizable Ischemic Myocardium Start of enrollment: 2007 Jan 01
Completed
Phase 1
Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction Start of enrollment: 2008 Mar 01
Unknown status
Phase 1, Phase 2
A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure Start of enrollment: 2008 Aug 01
Completed
Phase 2
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia Start of enrollment: 2010 Mar 01
Completed
Phase 2
Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia Start of enrollment: 2012 Jun 01
Completed
Phase 2
A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System Start of enrollment: 2012 Dec 01
Terminated
Phase 3
Patients With Intermittent Claudication Injected With ALDH Bright Cells Start of enrollment: 2013 Jun 01
Completed
Phase 2
Safety & Efficacy of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia (ATHENA II) Start of enrollment: 2014 Jan 01
Completed
Phase 2
Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy Start of enrollment: 2024 Mar 04
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

108 citations
Global position paper on cardiovascular regenerative medicine.
Francisco Fernández-Avilés, Ricardo Sanz-Ruiz, Andreu M. Climent, Lina Badimon, Roberto Bolli
European Heart Journal. 2017-09-01
671 citations
Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis.
Ahmed Abdel-Latif, Roberto Bolli, Imad M. Tleyjeh, Victor M. Montori, Emerson C. Perin
Archives of Internal Medicine. 2007-05-28
5 citations
Heart Rate Variability Measurement through a Smart Wearable Device: Another Breakthrough for Personal Health Monitoring?
Ke Li, Cristiano Cardoso, Angel Moctezuma-Ramirez, Abdelmotagaly Elgalad, Emerson Perin
International Journal of Environmental Research and Public Health. 2023-12-06

Lectures

Cell Society 2nd Annual Clinical Meeting
Medical Education Advocates, Coronado, California - 2/17/2012

Press Mentions

Dr. Emerson Perin Participates in UofL Clinical Trial for New Therapy for Heart FailureAugust 7th, 2024
Stem Cell Therapy Offers Potential New Treatment Option for People with Chronic Heart FailureMarch 8th, 2023
DREAM-HF Phase 3 Trial Results for Mesoblast Cell Therapy in Heart Failure Published in Journal of the American College of Cardiology (JACC)February 27th, 2023
Join now to see all

Grant Support

Combined Stem Cell And Assist Device Therapy For Heart FailureNational Heart, Lung, And Blood Institute2010–2011
Gadonanotubes As New MRI Nanolabels For Stem Cell TrackingNational Institute Of Biomedical Imaging And Bioengineering2009–2010